small molecule

AMRIX

CYCLOBENZAPRINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity

CompanyTEVA PHARMACEUTICALS INTERNATIONAL GMBH

Drug detail

Brand name	AMRIX
Active ingredient	CYCLOBENZAPRINE HYDROCHLORIDE
Strength	30MG
Dosage form	CAPSULE, EXTENDED RELEASE
Route	ORAL
Modality	Small molecule
FDA approval	February 2007
Marketing status	RX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.